RALPH SNYDERMAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RALPH SNYDERMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RALPH SNYDERMAN. RALPH SNYDERMAN is Director in CareDx, Inc. ($CDNA) and Director in ARGOS THERAPEUTICS INC ($ARGS) and Director in Liquidia Technologies Inc ($LQDA) and Director in iRhythm Technologies, Inc. ($IRTC) and Director in Press Ganey Holdings, Inc. ($PGND).
Latest Insider Trading Transactions of RALPH SNYDERMAN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARGS, CDNA, IRTC, LIQDA, PGND
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 19 2021 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Sell | S | 88.88 | 12,000 | 1,066,513 | 72,672 | 84.7 K to 72.7 K (-14.17 %) |
| Oct 02 2020 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 370 | 0 | 84,457 | 84.1 K to 84.5 K (+0.44 %) |
| Jul 06 2020 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 439 | 0 | 84,087 | 83.6 K to 84.1 K (+0.52 %) |
| Jul 06 2020 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 557 | 0 | 80,458 | 79.9 K to 80.5 K (+0.70 %) |
| Jun 23 2020 | IRTC | iRhythm Technologi ... | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 1,056 | 0 | 5,312 | 4.3 K to 5.3 K (+24.81 %) |
| Jun 23 2020 | LIQDA | Liquidia Technolog ... | SNYDERMAN RALPH | Director | Option Exercise | A | 10.97 | 20,000 | 219,400 | 20,000 | |
| Jun 19 2020 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Option Exercise | A | 31.35 | 4,978 | 156,060 | 4,978 | |
| Jun 19 2020 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Option Exercise | A | 31.35 | 4,978 | 156,060 | 4,978 | |
| Jun 19 2020 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 3,190 | 0 | 83,091 | 79.9 K to 83.1 K (+3.99 %) |
| Jun 19 2020 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 3,190 | 0 | 83,091 | 79.9 K to 83.1 K (+3.99 %) |
| May 13 2020 | IRTC | iRhythm Technologi ... | SNYDERMAN RALPH | Director | Sell | S | 134.55 | 250 | 33,638 | 4,256 | 4.5 K to 4.3 K (-5.55 %) |
| Mar 05 2020 | IRTC | iRhythm Technologi ... | SNYDERMAN RALPH | Director | Sell | S | 98.85 | 650 | 64,253 | 4,506 | 5.2 K to 4.5 K (-12.61 %) |
| Mar 04 2020 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Option Exercise | M | 3.70 | 14,598 | 53,998 | 0 | |
| Mar 04 2020 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Buy | M | 3.70 | 14,598 | 53,998 | 79,901 | 65.3 K to 79.9 K (+22.35 %) |
| Jan 03 2020 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 653 | 0 | 65,303 | 64.7 K to 65.3 K (+1.01 %) |
| Jan 03 2020 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 653 | 0 | 65,303 | 64.7 K to 65.3 K (+1.01 %) |
| Oct 02 2019 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 541 | 0 | 64,650 | 64.1 K to 64.7 K (+0.84 %) |
| Sep 03 2019 | LQDA | Liquidia Technolog ... | SNYDERMAN RALPH | Director | Option Exercise | A | 4.52 | 7,500 | 33,900 | 7,500 | |
| Jul 02 2019 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 312 | 0 | 64,109 | 63.8 K to 64.1 K (+0.49 %) |
| Jun 19 2019 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Option Exercise | A | 38.26 | 4,152 | 158,856 | 4,152 | |
| Jun 19 2019 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 2,613 | 0 | 63,797 | 61.2 K to 63.8 K (+4.27 %) |
| May 24 2019 | IRTC | iRhythm Technologi ... | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 1,764 | 0 | 5,156 | 3.4 K to 5.2 K (+52.00 %) |
| Apr 26 2019 | LQDA | Liquidia Technolog ... | SNYDERMAN RALPH | Director | Option Exercise | M | 4.71 | 4,085 | 19,240 | 0 | |
| Apr 26 2019 | LQDA | Liquidia Technolog ... | SNYDERMAN RALPH | Director | Option Exercise | M | 3.87 | 463 | 1,792 | 0 | |
| Apr 26 2019 | LQDA | Liquidia Technolog ... | SNYDERMAN RALPH | Director | Option Exercise | M | 2.69 | 946 | 2,545 | 0 | |
| Apr 26 2019 | LQDA | Liquidia Technolog ... | SNYDERMAN RALPH | Director | Buy | M | 4.71 | 4,085 | 19,240 | 30,356 | 26.3 K to 30.4 K (+15.55 %) |
| Apr 26 2019 | LQDA | Liquidia Technolog ... | SNYDERMAN RALPH | Director | Buy | M | 3.87 | 463 | 1,792 | 26,271 | 25.8 K to 26.3 K (+1.79 %) |
| Apr 26 2019 | LQDA | Liquidia Technolog ... | SNYDERMAN RALPH | Director | Buy | M | 2.69 | 946 | 2,545 | 25,808 | 24.9 K to 25.8 K (+3.81 %) |
| Apr 19 2019 | IRTC | iRhythm Technologi ... | SNYDERMAN RALPH | Director | Option Exercise | M | 41.04 | 250 | 10,260 | 3,839 | |
| Apr 19 2019 | IRTC | iRhythm Technologi ... | SNYDERMAN RALPH | Director | Buy | M | 41.04 | 250 | 10,260 | 3,392 | 3.1 K to 3.4 K (+7.96 %) |
| Apr 19 2019 | IRTC | iRhythm Technologi ... | SNYDERMAN RALPH | Director | Option Exercise | M | 41.04 | 250 | 10,260 | 3,839 | |
| Apr 19 2019 | IRTC | iRhythm Technologi ... | SNYDERMAN RALPH | Director | Buy | M | 41.04 | 250 | 10,260 | 3,392 | 3.1 K to 3.4 K (+7.96 %) |
| Apr 03 2019 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 343 | 0 | 61,184 | 60.8 K to 61.2 K (+0.56 %) |
| Jan 03 2019 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 356 | 0 | 70,841 | 70.5 K to 70.8 K (+0.51 %) |
| Oct 02 2018 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 489 | 0 | 70,485 | 70 K to 70.5 K (+0.70 %) |
| Jul 03 2018 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 1,197 | 0 | 69,996 | 68.8 K to 70 K (+1.74 %) |
| Jul 03 2018 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Option Exercise | A | 14.74 | 15,000 | 221,100 | 15,000 | |
| Jul 03 2018 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 5,000 | 0 | 68,799 | 63.8 K to 68.8 K (+7.84 %) |
| Jun 06 2018 | IRTC | iRhythm Technologi ... | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 1,193 | 0 | 3,142 | 1.9 K to 3.1 K (+61.21 %) |
| Apr 04 2018 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 2,221 | 0 | 63,799 | 61.6 K to 63.8 K (+3.61 %) |
| Jan 02 2018 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 1,924 | 0 | 61,578 | 59.7 K to 61.6 K (+3.23 %) |
| Nov 13 2017 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Option Exercise | A | 5.49 | 6,679 | 36,668 | 6,679 | |
| Nov 13 2017 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Option Exercise | D | 12.40 | 10,948 | 135,755 | 0 | |
| Oct 04 2017 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 5,713 | 0 | 59,654 | 53.9 K to 59.7 K (+10.59 %) |
| Jul 19 2017 | IRTC | iRhythm Technologi ... | SNYDERMAN RALPH | Director | Option Exercise | A | 41.04 | 4,089 | 167,813 | 4,089 | |
| Jul 19 2017 | IRTC | iRhythm Technologi ... | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 1,949 | 0 | 1,949 | 0 to 1.9 K |
| Jul 14 2017 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Option Exercise | A | 1.22 | 15,000 | 18,300 | 15,000 | |
| Jul 14 2017 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 5,000 | 0 | 53,941 | 48.9 K to 53.9 K (+10.22 %) |
| Jan 04 2017 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 3,463 | 0 | 36,023 | 32.6 K to 36 K (+10.64 %) |
| Jan 04 2017 | ARGS | ARGOS THERAPEUTICS ... | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 573 | 0 | 573 | 0 to 573 |
| Dec 13 2016 | ARGS | ARGOS THERAPEUTICS ... | SNYDERMAN RALPH | Director | Option Exercise | A | 4.90 | 30,000 | 147,000 | 30,000 | |
| Oct 25 2016 | PGND | Press Ganey Holdin ... | SNYDERMAN RALPH | Director | Sell | D | 40.50 | 28,770 | 1,165,185 | 0 | 28.8 K to 0 (-100.00 %) |
| Oct 04 2016 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 2,614 | 0 | 32,560 | 29.9 K to 32.6 K (+8.73 %) |
| Jul 19 2016 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Option Exercise | A | 4.95 | 9,745 | 48,238 | 9,745 | |
| Jul 19 2016 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 5,000 | 0 | 29,946 | 24.9 K to 29.9 K (+20.04 %) |
| Jul 06 2016 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 1,653 | 0 | 24,946 | 23.3 K to 24.9 K (+7.10 %) |
| Jun 23 2016 | PGND | Press Ganey Holdin ... | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 3,402 | 0 | 28,770 | 25.4 K to 28.8 K (+13.41 %) |
| Jun 20 2016 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Option Exercise | A | 5.02 | 5,255 | 26,380 | 5,255 | |
| Apr 05 2016 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 2,247 | 0 | 23,293 | 21 K to 23.3 K (+10.68 %) |
| Jan 05 2016 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 2,112 | 0 | 21,046 | 18.9 K to 21 K (+11.15 %) |
| Oct 05 2015 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 1,739 | 0 | 18,934 | 17.2 K to 18.9 K (+10.11 %) |
| Jul 06 2015 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 2,117 | 0 | 17,195 | 15.1 K to 17.2 K (+14.04 %) |
| Jun 17 2015 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Option Exercise | A | 6.08 | 5,255 | 31,950 | 5,255 | |
| May 22 2015 | PGND | Press Ganey Holdin ... | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 5,000 | 0 | 25,368 | 20.4 K to 25.4 K (+24.55 %) |
| Apr 24 2015 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Option Exercise | M | 2.33 | 11,678 | 27,198 | 0 | |
| Apr 24 2015 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Buy | M | 2.33 | 11,678 | 27,198 | 15,078 | 3.4 K to 15.1 K (+343.47 %) |
| Apr 03 2015 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 1,440 | 0 | 3,400 | 2 K to 3.4 K (+73.47 %) |
Page: 1